Added to YB: 2025-01-13
Pitch date: 2025-01-10
RCEL [bullish]
AVITA Medical, Inc.
-61.85%
current return
Author Info
Steve Wagner provides in-depth analysis of my favorite individual companies. Sign up for the newsletter.
Company Info
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Market Cap
$149.6M
Pitch Price
$9.07
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.05
P/E
-2.86
EV/Sales
2.38
Sector
Biotechnology
Category
growth
Avita Medical Declines 30% on Revised Guidance
RCEL: Q4 rev $18.4M (+30% YoY) below guidance due to hospital inventory adjustments. 2024 rev $64.3M (+29% YoY). 2025 guidance $100-106M (+55-65%). New products: PermeaDerm, RECELL GO, Cohealyx. Breakeven/profitability now Q4 2025. Thesis intact despite setback. Adding to position.
Read full article (2 min)